SCHEDULE 13G/A: Investment Funds Disclose 4.3% Passive Stake in Atossa Therapeutics

Sentiment:

Beneficial Ownership Disclosure


CVI Investments, Inc. and Heights Capital Management, Inc. have disclosed a passive 4.3% beneficial ownership stake in Atossa Therapeutics, Inc. as of December 31, 2024.

Summary

  • CVI Investments, Inc. and Heights Capital Management, Inc. (collectively, 'Reporting Persons') have filed an Amendment No. 2 to Schedule 13G regarding their beneficial ownership in Atossa Therapeutics, Inc.
  • As of December 31, 2024, the Reporting Persons collectively beneficially own 5,662,500 shares of Atossa Therapeutics, Inc. common stock.
  • This ownership represents 4.3% of the company's outstanding common stock.
  • The shares beneficially owned consist of shares issuable upon the exercise of warrants.
  • Heights Capital Management, Inc. serves as the investment manager to CVI Investments, Inc. and exercises shared voting and dispositive power over these shares.
  • The filing indicates that the securities were not acquired or held for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: Neutral, as this is a factual disclosure of passive ownership and does not contain performance or forward-looking statements from the company.

Future Outlook

NA

Industry Context

NA

Key Dates

DateDescription
11/08/2024Date as of which Atossa Therapeutics, Inc. reported 125,801,254 shares outstanding in its Quarterly Report on Form 10-Q
12/31/2024Date of event which requires filing of this statement (beneficial ownership calculation date)
02/07/2025Date of filing of this Schedule 13G Amendment No. 2

Keywords

Atossa Therapeutics, CVI Investments, Heights Capital Management, Schedule 13G, Beneficial Ownership, Common Stock, Investment Management, SEC Filing, Biotechnology

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.